Trials / Unknown
UnknownNCT04865900
Prevalence of Perimyocarditis After Covid-19 Vaccine
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine whether there is a higher prevalence of perimyocarditis after undergoing vaccination for Covid-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Laboratory Blood Tests | Blood tests to determine liver and kidney functioning, total blood count, and troponin levels |
| DIAGNOSTIC_TEST | ECG | ECG to determine heart rate and functioning |
| DIAGNOSTIC_TEST | PCR | PCR test to determine whether patient has Covid19 |
| DIAGNOSTIC_TEST | Antibody test | Antibody test to determine level of antibodies to Covid19 |
| DIAGNOSTIC_TEST | Echocardiography | If Troponin level elevated echocardiography to determine heart function |
| DIAGNOSTIC_TEST | MRI | If Troponin level elevated MRI to determine heart function |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2021-04-29
- Last updated
- 2021-04-29
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04865900. Inclusion in this directory is not an endorsement.